2022
DOI: 10.1007/s11426-022-1340-6
|View full text |Cite
|
Sign up to set email alerts
|

Atom engineering-regulated in situ transition of Cu(I)-Cu(II) for efficiently overcoming cancer drug resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 37 publications
0
4
0
Order By: Relevance
“…Fluorescence content was measured using flow cytometry with at least 20 000 cells per independent sample. The cycle distribution of cell populations was analyzed as previously described 22 .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Fluorescence content was measured using flow cytometry with at least 20 000 cells per independent sample. The cycle distribution of cell populations was analyzed as previously described 22 .…”
Section: Methodsmentioning
confidence: 99%
“…When the cell density reached 80%-90%, the cells in each group were treated with corresponding operations and cultured for 48 h. Lysis, denaturation, electrophoretic separation and western blotting of total intracellular proteins were performed as described in previous studies. The primary antibodies were incubated overnight, then the secondary antibody was incubated and the image were photographed by the Thermo Fisher Gel Imaging system 22 .…”
Section: Methodsmentioning
confidence: 99%
“…Over the past few years, nano-platforms based on transition metals have been thoroughly researched for the treatment of tumours. [13][14][15][16][17] Owing to their unique optical properties compared with conventional therapeutic treatments, transition metals are often used as photosensitizers for PDT and PTT. They play an important role in minimising adverse drug reactions and improving the effectiveness of cancer treatments.…”
Section: Introductionmentioning
confidence: 99%
“…Thanks to the unique electronic structure that facilitates charge transfer and the unsaturated coordination environment of isolated single atoms, SACs not only possess extremely uniform microstructure and active site distribution, but also exhibit excellent catalytic activity and ideal selectivity [31][32][33][34][35][36]. The appeal advantage allows SACs to maximize the use of metal atoms and achieve satisfactory cancer treatment results at relatively low metal concentrations [37][38][39][40][41][42]. Importantly, the active sites are easy to accurately identify and characterize, which facilitates the further elucidating and understanding of the structure-performance relation and the catalytic mechanism, thus facilitating the oriented and rational design of more advanced SACs [43][44][45][46][47].…”
Section: Introductionmentioning
confidence: 99%